{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:15:21Z","timestamp":1791310521161,"version":"4.3.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.juro.2008.03.031","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T16:36:14Z","timestamp":1210955774000},"page":"116-120","source":"Crossref","is-referenced-by-count":18,"title":["Safety and Side Effects of Immediate Instillation of Apaziquone Following Transurethral Resection in Patients With Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"180","author":[{"given":"K.","family":"Hendricksen","sequence":"first","affiliation":[{"name":"Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gleason","sequence":"additional","affiliation":[{"name":"Department of Urology, Advanced Clinical Therapy, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Urology, South Orange County Medical Research Center, Laguna Hills, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saltzstein","sequence":"additional","affiliation":[{"name":"Department of Urology, San Antonio Research, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gershman","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute for Advanced Urology, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lerner","sequence":"additional","affiliation":[{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Witjes","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2008.03.031_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2008.03.031_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"Oosterlinck","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib3","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib5","series-title":"Guidelines, European Association of Urology","first-page":"3","article-title":"Guidelines on TaT1 (non-muscle invasive) bladder cancer","author":"Oosterlinck","year":"2006"},{"key":"10.1016\/j.juro.2008.03.031_bib6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.06.007","article-title":"Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response","volume":"176","author":"van der Heijden","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib7","series-title":"Histological typing of urinary bladder tumours","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.juro.2008.03.031_bib8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","article-title":"TNM Classification of Malignant Tumors, fifth edition (1997)","volume":"80","author":"Sobin","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2008.03.031_bib9","doi-asserted-by":"crossref","unstructured":"Vainchtein LD, Rosing H, Mirejovsky D, Huynh V, Lenaz L, Hillebrand MJ et al: Quantitative analysis of EO9 (apaziquone) and its metabolite EO5a in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray tandem mass spectrometry. J Mass Spectrom 206; 41: 1268.","DOI":"10.1002\/jms.1086"},{"key":"10.1016\/j.juro.2008.03.031_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0302-2838(02)00260-9","article-title":"Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma","volume":"42","author":"Kaasinen","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0022-5347(17)39174-7","article-title":"Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder","volume":"142","author":"Pan","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","article-title":"The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up","volume":"155","author":"Tolley","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5347(01)67608-0","volume":"153","author":"Bouffioux","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0360-3016(92)90509-G","article-title":"Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodents","volume":"22","author":"Workman","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.juro.2008.03.031_bib16","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/0959-8049(96)00120-7","article-title":"Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9","volume":"32A","author":"McLeod","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2008.03.031_bib17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0022-5347(05)67021-8","article-title":"Early complications of endoscopic treatment for superficial bladder tumors","volume":"164","author":"Collado","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eururo.2004.05.003","article-title":"One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients","volume":"46","author":"Oddens","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-5347(17)36198-0","volume":"149","author":"Oosterlinck","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-410X.1994.tb07487.x","article-title":"The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial","volume":"73","author":"Witjes","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2008.03.031_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.urology.2005.10.028","article-title":"Review pathology in a diagnostic bladder cancer trial: effect of patient risk category","volume":"67","author":"Witjes","year":"2006","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708005910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708005910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2008.03.031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:26:32Z","timestamp":1651195592000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2008.03.031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1016\/j.juro.2008.03.031"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2008.03.031","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}